1. A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience. (29th April 2022) Authors: Kuhnl, Andrea; Roddie, Claire; Kirkwood, Amy A.; Tholouli, Eleni; Menne, Tobias; Patel, Amit; Besley, Caroline; Chaganti, Sridhar; Sanderson, Robin; O'Reilly, Maeve; Norman, Jane; Osborne, Wendy; Bloor, Adrian; Lugthart, Sanne; Malladi, Ram; Patten, Piers E. M.; Neill, Lorna; Martinez‐Cibrian, Nu... Journal: British journal of haematology Issue: Volume 198:Number 3(2022) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320. Issue 9 (1st September 2016) Authors: Townsend, William; Johnson, Rod J.; Pottinger, Bryson T.; Counsell, Nicholas; Smith, Paul; Chadwick, Humra; Evans, Katy; Wickham, Caroline; Rudin, Claudius E Journal: Leukemia & lymphoma Issue: Volume 57:Issue 9(2016:Sep.) Page Start: 2232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. Issue 11 (27th November 2021) Authors: Collins, Graham P.; Eyre, Toby A.; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fields, Paul A.; Krasniqi, Fatime; Soussain, Carole; Stathis, Anastasios; Andjelkovic, Nebojsa; Cunningham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel... Journal: HemaSphere Issue: Volume 5:Issue 11(2021) Page Start: e656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups. Issue 6 (20th March 2013) Authors: Marafioti, Teresa; Copie‐Bergman, Christiane; Calaminici, Maria; Paterson, Jennifer C; Shende, Vishvesh H; Liu, Hongxiang; Baia, Maryse; Ramsay, Alan D; Agostinelli, Claudio; Brière, Josette; Clear, Andrew; Du, Ming‐Qing; Piccaluga, Pier Paolo; Masir, Noraidah; Nacheva, Elizabeth P; Sujobert, Pie... Journal: Histopathology Issue: Volume 62:Issue 6(2013) Page Start: 860 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials. (5th July 2018) Authors: El‐Sharkawi, Dima; Ng, Chin‐Hin; Payne, Elspeth M.; Yong, Kwee L.; Ardeshna, Kirit M.; Khwaja, Asim; Townsend, William; Popat, Rakesh Journal: British journal of haematology Issue: Volume 185:Number 2(2019) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline. (22nd February 2022) Authors: Follows, George A.; Barrington, Sally F.; Bhuller, Kaljit S.; Culligan, Dominic J.; Cutter, David J.; Gallop‐Evans, Eve; Kassam, Shireen; Osborne, Wendy; Sadullah, Shalal; Townsend, William; Uttenthal, Benjamin J.; Collins, Graham P. Journal: British journal of haematology Issue: Volume 197:Number 5(2022) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID‐19 with B‐cell malignancies. (21st September 2021) Authors: Fox, Thomas A.; Kirkwood, Amy A.; Enfield, Louise; O'Reilly, Maeve; Arulogun, Suzanne; D'Sa, Shirley; O'Nions, Jenny; Kavi, Janki; Vitsaras, Evan; Townsend, William; Burns, Siobhan O.; Gohil, Satyen H.; Cwynarski, Kate; Thomson, Kirsty J.; Noursadeghi, Mahdad; Heyderman, Robert S.; Rampling, Tomm... Journal: British journal of haematology Issue: Volume 195:Number 5(2021) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real‐World Experience from 554 sequential core biopsies from a single centre. (2nd December 2020) Authors: Cohen, Oliver C.; Brodermann, Maximillian H.; Dervin, Aoife; Raja, Neel; Marafioti, Teresa; Otero, Sofia; Beale, Tim; Jawad, Susan; Ramsay, Alan; Pomplun, Sabine; Ardeshna, Kirit M.; Proctor, Ian; Townsend, William; Morley, Simon Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real‐World Experience from 554 sequential core biopsies from a single centre. (2nd December 2020) Authors: Cohen, Oliver C.; Brodermann, Maximillian H.; Dervin, Aoife; Raja, Neel; Marafioti, Teresa; Otero, Sofia; Beale, Tim; Jawad, Susan; Ramsay, Alan; Pomplun, Sabine; Ardeshna, Kirit M.; Proctor, Ian; Townsend, William; Morley, Simon Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ofatumumab is a feasible alternative anti‐CD20 therapy in patients intolerant of rituximab. (24th January 2018) Authors: Chen, Lucia Y.; Shah, Raakhee; Cwynarski, Kate; Lambert, Jonathan; McNamara, Christopher; Mohamedbhai, Sajir G.; Virchis, Andres; Townsend, William; D'Sa, Shirley; Ardeshna, Kirit M. Journal: British journal of haematology Issue: Volume 184:Number 3(2019) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗